Dogwood Therapeutics, Stock Current Ratio
| DWTX Stock | 8.44 1.84 27.88% |
Dogwood Therapeutics, fundamentals help investors to digest information that contributes to Dogwood Therapeutics,'s financial success or failures. It also enables traders to predict the movement of Dogwood Stock. The fundamental analysis module provides a way to measure Dogwood Therapeutics,'s intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Dogwood Therapeutics, stock.
Dogwood | Current Ratio |
Dogwood Therapeutics, Company Current Ratio Analysis
Dogwood Therapeutics,'s Current Ratio is calculated by dividing the Current Assets of a company by its Current Liabilities. It measures whether or not a company has enough cash or liquid assets to pay its current liability over the next fiscal year. The ratio is regarded as a test of liquidity for a company.
Dogwood Current Ratio Driver Correlations
Understanding the fundamental principles of building solid financial models for Dogwood Therapeutics, is extremely important. It helps to project a fair market value of Dogwood Stock properly, considering its historical fundamentals such as Current Ratio. Since Dogwood Therapeutics,'s main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Dogwood Therapeutics,'s historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Dogwood Therapeutics,'s interrelated accounts and indicators.
Click cells to compare fundamentals
Typically, short-term creditors will prefer a high current ratio because it reduces their overall risk. However, investors may prefer a lower current ratio since they are more concerned about growing the business using assets of the company. Acceptable current ratios may vary from one sector to another, but the generally accepted benchmark is to have current assets at least as twice as current liabilities (i.e., Current Ration of 2 to 1).
| Competition |
In accordance with the recently published financial statements, Dogwood Therapeutics, has a Current Ratio of 0.0 times. This is 100.0% lower than that of the Healthcare sector and 100.0% lower than that of the Biotechnology industry. The current ratio for all United States stocks is 100.0% higher than that of the company.
Dogwood Current Ratio Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Dogwood Therapeutics,'s direct or indirect competition against its Current Ratio to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Dogwood Therapeutics, could also be used in its relative valuation, which is a method of valuing Dogwood Therapeutics, by comparing valuation metrics of similar companies.Dogwood Therapeutics, is currently under evaluation in current ratio category among its peers.
Dogwood Fundamentals
| Return On Equity | -2.0 | ||||
| Return On Asset | -0.97 | ||||
| Current Valuation | 6.13 M | ||||
| Shares Outstanding | 1.33 M | ||||
| Shares Owned By Insiders | 21.48 % | ||||
| Shares Owned By Institutions | 2.44 % | ||||
| Number Of Shares Shorted | 38.19 K | ||||
| Price To Book | 8.60 X | ||||
| Net Income | (5.3 M) | ||||
| Total Debt | 358.55 K | ||||
| Book Value Per Share | 0.85 X | ||||
| Cash Flow From Operations | (4.87 M) | ||||
| Short Ratio | 0.01 X | ||||
| Earnings Per Share | (6.32) X | ||||
| Target Price | 13.83 | ||||
| Beta | 1.94 | ||||
| Market Capitalization | 8.17 M | ||||
| Total Asset | 4.17 M | ||||
| Retained Earnings | (61.47 M) | ||||
| Working Capital | 3.81 M | ||||
| Net Asset | 4.17 M |
About Dogwood Therapeutics, Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Dogwood Therapeutics,'s financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Dogwood Therapeutics, using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Dogwood Therapeutics, based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for Dogwood Stock Analysis
When running Dogwood Therapeutics,'s price analysis, check to measure Dogwood Therapeutics,'s market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Dogwood Therapeutics, is operating at the current time. Most of Dogwood Therapeutics,'s value examination focuses on studying past and present price action to predict the probability of Dogwood Therapeutics,'s future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Dogwood Therapeutics,'s price. Additionally, you may evaluate how the addition of Dogwood Therapeutics, to your portfolios can decrease your overall portfolio volatility.